Literature DB >> 10565566

Effects of in vivo soluble selectin gene introduction of lps-induced leukocyte accumulation in the murine lung.

K Abe1, T Arai, M Mori, H Kida, S Goya, H Matsuoka, T Osaki, I Tachibana, S Hayashi.   

Abstract

The selectin family adhesion molecules exert a crucial role in accumulation of leukocytes at the site of inflammation. To test the biological effects of soluble selectin on lung inflammation, we introduced an expression plasmid vector of soluble selectin gene via HVJ-liposome into a murine model of LPS-induced lung injury. The myeloperoxidase activity in LPS-injected mice was suppressed by the in vivo injection of soluble P-selectin gene relative to control mice. On the contrary, soluble E- or L-selectin genes did not exert suppressive effects. Our observations suggest that P-selectin plays a crucial role in the initial steps of lung inflammation, and exogenous introduction of soluble P-selectin by in vivo gene transfer method may be a useful strategy for regulating inflammation of the lung.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565566      PMCID: PMC7102382          DOI: 10.1023/a:1020238422788

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  25 in total

1.  Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo.

Authors:  U Gotsch; U Jäger; M Dominis; D Vestweber
Journal:  Cell Adhes Commun       Date:  1994-04

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

3.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

Authors:  M P Bevilacqua; S Stengelin; M A Gimbrone; B Seed
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

4.  A monoclonal antibody to a membrane glycoprotein binds only to activated platelets.

Authors:  R P McEver; M N Martin
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

5.  Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats.

Authors:  M S Mulligan; J Varani; M K Dame; C L Lane; C W Smith; D C Anderson; P A Ward
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

6.  Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1.

Authors:  A E Koch; M M Halloran; C J Haskell; M R Shah; P J Polverini
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962

7.  Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140).

Authors:  M S Mulligan; M J Polley; R J Bayer; M F Nunn; J C Paulson; P A Ward
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Characterization of rat LECAM-1 (L-selectin) by the use of monoclonal antibodies and evidence for the presence of soluble LECAM-1 in rat sera.

Authors:  T Tamatani; F Kitamura; K Kuida; M Shirao; M Mochizuki; M Suematsu; G W Schmid-Schönbein; K Watanabe; S Tsurufuji; M Miyasaka
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

9.  Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs.

Authors:  Y Suzuki; T Tanigaki; D Heimer; W Z Wang; W G Ross; H H Sussman; T A Raffin
Journal:  Am Rev Respir Dis       Date:  1992-02

10.  Ibuprofen plus prostaglandin E1 in a septic porcine model of adult respiratory distress syndrome.

Authors:  E A Davies; A J Campbell; M J Devine; S M Steinberg; C T Cloutier
Journal:  J Trauma       Date:  1989-03
View more
  1 in total

1.  Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis.

Authors:  Seiji Hayashi; Kin'ya Abe; Hiroto Matsuoka; Sho Goya; Hiroshi Morishita; Masahide Mori; Toru Arai; Hiroshi Kida; Kazumi Nishino; Yoshito Takeda; Tadashi Osaki; Isao Tachibana; Kentaro Kimura; Soichiro Yokota; Yoshikazu Inoue; Mitsunori Sakatani
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.